Building the Next Generation Botulinum Toxin Platform.
Obigen Pharma is pioneering next-generation botulinum toxin therapeutics that extend treatment durability, enhance patient outcomes, and expand the possibilities of toxin-based medicine.
Beyond aesthetics, we view botulinum toxin as a transformative biologic platform with applications across multiple therapeutic areas, including neurology, urology, and chronic disease management.
Through scientific innovation and global development capabilities, we seek to bring differentiated biologic therapies to patients worldwide.